Jason C. Foster has held leading roles in consulting, healthcare and technology companies for over 20 years in the US, UK and Europe. He spent 10 of those years building Indivior PLC (LSE: INDV) which exited in a £3.5B enterprise value listing on the LSE in December 2014. Jason is currently CEO and Executive Director for Ori Biotech, a cell and gene therapy manufacturing technology company with offices in London and New Jersey which raised a $100M Series B in December 2021.  Jason also serves as a Non-Executive Director of London-based healthtech start-ups GripAble and Credentially, as well as Auxita Pty, an Australian healthcare data platform and hystrix medical AG, a Swiss B2B marketplace for medical products. As the Managing Director of Health Equity Consulting for the last 6 years, he has advised private equity & venture capital funds, family offices, accelerators and healthTech start-ups. In addition to his work at HEC, Jason is a strategic advisor to Joyance Partners, a Venture Partner with Hambro Perks and active in mentoring healthTech startups as Co-Chair of the Tech London Advocates (TLA) healthTech working group.  Jason also volunteers as a Trustee for the UK registered charity, Painkiller Addiction Information Network (P.A.I.N).